1.
Rincon Lopez JV, Pérez Valencia MM, Cerón Gómez AC, Sánchez Otálora GC, Díaz Báez DA. Clinical outcomes cause by respiratory syncytial virus infection during the first two years of life in patients of a kangaroo program who received complete prophylaxis with palivizumab. Retrospective cohort study. Pediatria. [Internet]. 2023 Mar. 31 [cited 2024 May 18];56(1):e397. Available from: https://revistapediatria.emnuvens.com.br/rp/article/view/397